Organ support & nutrition

In-Hospital Mortality and Associated Risk Factors in Cardiac Surgery–Related Perioperative Acute Kidney Injury Patients Treated with Continuous Renal Replacement Therapy: A Retrospective Cohort Study

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

The SOFA score at CRRT initiation serves as an independent predictor of in-hospital mortality in CS-AKI patients requiring CRRT, outperforming both the APACHE II score and the EuroSCORE II score. IABP use and a mechanical ventilation time >96 hours also were independent predictors of in-hospital mortality.

Study context

Population
Adults with cardiac surgery-related perioperative AKI requiring continuous renal replacement therapy (CRRT), cardiac surgery intensive care unit (ICU), 2013–2022
Outcome
In-hospital mortality and independent predictors (multivariable Cox regression)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

In-hospital mortality rate

50.5%

SOFA score, per 1-point increase: HR

1.46

95% CI 1.36–1.56

Intra-aortic balloon pump (IABP) use: HR

2.11

95% CI 1.30–3.42

Mechanical ventilation time >96 hours: HR

3.06

95% CI 1.82–5.15

Observational data: associations, not effects.

Further findings

OutcomeSOFAAPACHE IIEuroSCORE II
Predictive accuracy for in-hospital mortality (ROC analysis)
AUC0.930.720.61

Predictive accuracy for in-hospital mortality (ROC analysis)

SOFA significantly greater predictive accuracy than APACHE II and EuroSCORE II

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

In-Hospital Mortality and Associated Risk Factors in Cardiac Surgery–Related Perioperative Acute Kidney Injury Patients Treated with Continuous Renal Replacement Therapy: A Retrospective Cohort Study. J Cardiothorac Vasc Anesth. Published 22 April 2026. doi:10.1053/j.jvca.2026.04.020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.